comprehensive -WSS

comprehensive

author：fashion 2025-10-01 13:45:50 Page View：46

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： California wildfire smoke linked to 52,000 early deaths, study says
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

focus

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Sanders adds drug shortage policies to pandemic preparedness bill

Sen.BernieSanders(I-Vt.)addedthreedrugshortagemeasurestoapandemic-preparednessbillthathiscommitteewi

State Dept. review finds Biden bears some blame for Afghanistan failures

3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

WHO calls for emergency meeting on new China virus, as cases spread

FABRICECOFFRINI/AFP/GettyImagesTheWorldHealthOrganizationannouncedMondaythatitwouldconveneanexpertpa